Invention Grant
US09278100B2 Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
有权
用于治疗实体瘤的Bruton酪氨酸激酶抑制剂
- Patent Title: Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
- Patent Title (中): 用于治疗实体瘤的Bruton酪氨酸激酶抑制剂
-
Application No.: US13341695Application Date: 2011-12-30
-
Publication No.: US09278100B2Publication Date: 2016-03-08
- Inventor: Lee Honigberg , Erik Verner , Joseph Buggy , David Loury , Wei Chen
- Applicant: Lee Honigberg , Erik Verner , Joseph Buggy , David Loury , Wei Chen
- Applicant Address: US CA Sunnyvale
- Assignee: Pharmacyclics LLC
- Current Assignee: Pharmacyclics LLC
- Current Assignee Address: US CA Sunnyvale
- Agency: Foley Hoag LLP
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61P35/00 ; A61K31/00 ; A61K31/52 ; A61K31/337 ; A61K31/675 ; A61K31/704 ; A61K33/24 ; A61K39/395 ; A61K45/06
Abstract:
Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
Public/Granted literature
- US20130005746A1 INHIBITORS OF BRUTONS TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS Public/Granted day:2013-01-03
Information query
IPC分类:
